1. Public Health Agency of Canada. Cervical Cancer Screening in Canada: 1998 Surveillance Report. Ottawa, ON: Public Works and Government Services Canada, 2002. Available at:
https://doi.org/www.phac-aspc.gc.ca
/publicat/ccsicdccuac/index-eng.php (Accessed October 14, 2008).
2. Canadian Cancer Society/National Cancer Institute of Canada. Canadian Cancer Statistics 2008. Toronto, ON: Canadian Cancer Society/National Cancer Institute of Canada, 2008. Available at:
https://doi.org/www.cancer.ca
/statistics (Accessed September 18, 2008).
3. Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, et al. for the Canadian Cervical Cancer Screening Trial Study Group. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med 2007;357(16):1579–88.
4. Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, et al. on behalf of the New Technologies for Cervical Cancer Screening Working Group. Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test. J Natl Cancer Inst 2008;100(7):492–501.
5. Kotaniemi-Talonen L, Anttila A, Malila N, Tarkkanen J, Laurila P, Hakama M, et al. Screening with a primary human papillomavirus test does not increase detection of cervical cancer and intraepithelial neoplasia 3. Eur J Cancer 2008;44(4):565–71.